Emanuel Yaakobov
Gastroenterology · Forest Hills, NYNPI 1194319087
Payments from drug & device makers
Across 575 payments — averaging $34.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ardelyx, Inc.$4K
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Gilead$1K
- Intra-sana Laboratories$1K
- Johnson & Johnson$828
- plus $8K from 21 others
What the payments were for
- Speaking & faculty fees$2,63513%
- Food & beverage$17,07586%
- Education$1011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ardelyx, Inc. | 28 | $3,582 |
| AbbVie | 59 | $2,541 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 92 | $2,285 |
| Gilead | 52 | $1,472 |
| Intra-sana Laboratories | 16 | $1,302 |
| Johnson & Johnson | 33 | $828 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $824 |
| E.r. Squibb & Sons, L.L.C. | 5 | $686 |
| Ironwood Pharmaceuticals, Inc | 28 | $676 |
| Celltrion USA Inc. | 15 | $628 |
| Redhill Biopharma Inc. | 27 | $583 |
| Aimmune Therapeutics, Inc. | 20 | $531 |
| Madrigal Pharmaceuticals | 14 | $508 |
| Nestle Healthcare Nutrition Inc. | 21 | $483 |
| Bristol Myers Squibb | 33 | $451 |
| Phathom Pharmaceuticals, Inc. | 18 | $424 |
| Merck | 18 | $423 |
| Intercept Pharmaceuticals, Inc. | 12 | $385 |
| Lilly USA, LLC | 11 | $376 |
| Sanofi | 9 | $233 |
| Pfizer | 9 | $149 |
| Ipsen Biopharmaceuticals, Inc | 5 | $131 |
| Braintree Laboratories, Inc. | 5 | $104 |
| Vivus LLC | 4 | $74 |
| Ferring Pharmaceuticals Inc. | 3 | $59 |
| QOL Medical, LLC | 2 | $42 |
| Organon | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,811 in reported general payments places this provider in the 80th percentile of 1,682 gastroenterology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 1,133 | $611,265 |
| ZenpepLipase/Protease/Amylase | 254 | $520,369 |
| CreonLipase/Protease/Amylase | 294 | $387,114 |
| RinvoqUpadacitinib | 24 | $168,748 |
| IbsrelaTenapanor Hcl | 88 | $147,383 |
| DexilantDexlansoprazole | 401 | $117,181 |
| VemlidyTenofovir Alafenamide | 80 | $110,487 |
| XifaxanRifaximin | 26 | $59,650 |
| MotegrityPrucalopride Succinate | 105 | $57,500 |
| VoqueznaVonoprazan Fumarate | 63 | $39,508 |
| TrulancePlecanatide | 52 | $26,516 |
| Dexlansoprazole DrDexlansoprazole | 141 | $23,517 |
| NexiumEsomeprazole Magnesium | 84 | $21,538 |
| TaliciaOmeprazole/Amoxicill/Rifabutin | 25 | $19,373 |
| Mesalamine | 36 | $11,554 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon, Rinvoq | $2,541 | $1,167,1261,451 claims |
| Aimmune Therapeutics, Inc.Zenpep | $531 | $520,369254 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Dexilant, Motegrity | $824 | $174,681506 claims |
| Ardelyx, Inc.Ibsrela | $3,582 | $147,38388 claims |
| GileadVemlidy | $1,472 | $110,48780 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance, Apriso | $2,285 | $92,13790 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $424 | $39,50863 claims |
| Redhill Biopharma Inc.Talicia | $583 | $19,37325 claims |
| Braintree Laboratories, Inc.Sutab | $104 | $1,89212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,682 gastroenterology providers in New York.
Other gastroenterology in Forest Hills
- Michael GerdisYonkers$11.9M
- David HudesmanNew York$3.6M
- Ellen ScherlNew York$2.9M
- Igor GrosmanBrooklyn$2.8M
- Bruce SandsNew York$2.8M
- Arun SwaminathNew York$2.7M
- Sonal KumarNew York$2.3M
- David Carr LockeNew York$2.1M
- Arthur KornbluthNew York$1.9M
- Maya SrivastavaWilliamsville$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.